Anaplastic thyroid cancer: current capabilities of an oncologist

Continuous development of oncology as a science in the last decades and years led to noticeable improvement treatment outcomes for patients with various malignant tumors. Diagnostics, surgery, radiotherapy significantly contributed this improvement, however they cannot be compared progress achieved through advancements our knowledge genetic structure tumors subsequent pharmacology which allowed achieve qualitatively better survival oncological patients. These did not leave out such serious highly lethal, though fortunately rare, disease anaplastic thyroid cancer. This article is dedicated possibilities using checkpoint inhibitors pathology increase expected life span